Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR)
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P187
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, Charu
Article History
First Online: 6 November 2014